Healthcare

  Aptamers Market is projected to grow from US$ 205.40 million in 2019 to US$ 985.44 million by 2030. Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are the major key driving factors responsible for the growth of global aptamers market. Low cost and high efficacy in binding to large molecules compared to antibodies and the patent expiration of systemic evolution of ligands by exponential enrichment technology (SELEX) which boosts the global market positively. The report "Global Aptamers Market, By Type (Nucleic Acid and Peptides (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), By Application (Diagnostics, Therapeutics, and Research and Development), and Region - Global Forecast to 2030" Key Highlights: In September 2018, Base Pair Biotechnologies was awarded for discovering aptamers to canine oncology biomarkers. In April 2019, Agilent an...

Global Critical Care Equipment Market accounted for US$ 2.43 billion in 2020 and is estimated to be US$ 5.02 billion by 2030 and is anticipated to register a CAGR of 7.50%. Critical care is specialist treatment for individuals who are facing life-threatening diseases and require round-the-clock monitoring and care. Intensive care equipment is used in intensive care units to give care and monitor the health of patients 24 hours a day, seven days a week. Cardiac support equipment, pain management equipment, emergency resuscitation equipment, life support, patient monitoring equipment, and breathing equipment are all examples of critical care equipment used in intensive care units. For individuals with breathing problems, a ventilator, also known as a respirator, is used to help or control pulmonary ventilation. The report   " Global Critical Care Equipment Market, By Product Type (Beds, Ventilators, Pulse Oximeters, Dialysis Equipment, and Others), By Application (Neurology, Cardiol...

  The Global Plastic Injection Molding for Medical Device Market accounted for US$ 82.7 million in 2020 and is estimated to be US$ 148.88 million by 2030 and is anticipated to register a CAGR of 6.1%. The medical plastic injection molding process is cost-efficient, and ideal for top volume production runs and applications requiring consistency and tight tolerances. This molding process is additionally used for medical device prototype development for the FDA approval process and to be used in laboratory testing. Since inception, the utilization of plastics within modern medicine has steadily increased. Medical devices that are manufactured from injection molded plastic have contributed to a discount in medical costs, communicable disease and pain management. High tech polymers are used within medical device prototype development and are commonly wont to create improved artificial limbs and devices that reduce the danger of infection. Medical plastic injection molding directly resul...